Choulwar Amol K. (2013). Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and safety of Antihyperparathyroidism and Antianginal D. NMIMS-SPPSPTM.
Cita Chicago Style (17a ed.)Choulwar Amol K. Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and Safety of Antihyperparathyroidism and Antianginal D. Mumbai: NMIMS-SPPSPTM, 2013.
Cita MLA (9a ed.)Choulwar Amol K. Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and Safety of Antihyperparathyroidism and Antianginal D. NMIMS-SPPSPTM, 2013.
Precaución: Estas citas no son 100% exactas.